BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8172800)

  • 1. Etoposide, leucovorin, 5-fluorouracil (ELF) combination chemotherapy for advanced gastric cancer: experience with two treatment schedules incorporating intravenous or oral etoposide.
    Taal BG; Teller FG; ten Bokkel Huinink WW; Boot H; Beijnen JH; Dubbelman R
    Ann Oncol; 1994 Jan; 5(1):90-2. PubMed ID: 8172800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of the modified regimen of etoposide, leucovorin and 5-fluorouracil for patients with advanced gastric cancer.
    Chiou TJ; Tung SL; Hsieh RK; Wang WS; Yen CC; Fan FS; Liu JH; Chen PM
    Jpn J Clin Oncol; 1998 May; 28(5):318-22. PubMed ID: 9703859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etoposide, leucovorin and 5-fluorouracil in advanced gastric cancer: a phase II study.
    Van Cutsem E; Filez L; Dewyspelaere J; Penninckx F; Janssens J
    Anticancer Res; 1995; 15(3):1079-80. PubMed ID: 7645929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
    Feliu J; González Barón M; García-Girón C; Espinosa E; García-Alfonso P; Belón J; Blanco E; Garrido P; Ordónez A; Gómez-Navarro J; Zamora P
    Cancer; 1996 Jul; 78(2):211-6. PubMed ID: 8673994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etoposide, l-leucovorin and fluorouracil (ELF) regimen in metastatic gastric cancer: a phase II study.
    Adamo V; Scimone A; Maisano R; Altavilla G; Ferraro G; Laudani A; Pergolizzi S; Zanghì M
    J Chemother; 1999 Feb; 11(1):74-7. PubMed ID: 10078785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of advanced gastric cancer with oral etoposide, leucovorin and tegafur: experience with an oral modification of the etoposide, leucovorin and 5-fluorouracil (ELF) regimen.
    Raderer M; Kornek GV; Hejna MH; Miholic J; Weinlaender G; Brodowicz T; Fiebiger WC; Valencak JB; Scheithauer W
    Eur J Cancer; 1998 Jun; 34(7):1128-30. PubMed ID: 9849466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer.
    Moehler M; Eimermacher A; Siebler J; Höhler T; Wein A; Menges M; Flieger D; Junginger T; Geer T; Gracien E; Galle PR; Heike M
    Br J Cancer; 2005 Jun; 92(12):2122-8. PubMed ID: 15942629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of advanced gastric cancer with a modified regimen of etoposide/leucovorin/5-fluorouracil.
    Chiou TJ; Kung SP; Hsieh RK; Fan S; Tzeng CH; Wei CH; Chen PM
    Cancer Invest; 1996; 14(3):197-201. PubMed ID: 8630679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
    Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY
    Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I-II study of 5-fluorouracil, leucovorin, doxorubicin, methotrexate, and long-term oral etoposide (FLAME) in unresectable or metastatic gastric cancer.
    Bjarnason GA; Cripps C; Goel R; Fine S; Oza AM; Skillings JR; Kerr I; Germond CJ; Moore MJ; Maroun JA; Franssen E; Dulude H
    Am J Clin Oncol; 1998 Dec; 21(6):537-42. PubMed ID: 9856651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dose folinic acid/etoposide/5-fluorouracil in advanced gastric cancer--a phase II study in elderly patients or patients with cardiac risk.
    Wilke H; Preusser P; Fink U; Achterrath W; Lenaz L; Stahl M; Schober C; Link H; Meyer HJ; Lucke B
    Invest New Drugs; 1990 Feb; 8(1):65-70. PubMed ID: 2345071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of the etoposide, leucovorin and fluorouracil combination for patients with advanced gastric cancer unsuitable for aggressive chemotherapy.
    di Bartolomeo M; Bajetta E; de Braud F; Bochicchio AM; Gebbia V; Bozzetti F; Doci R; Bonfanti G; Cozzaglio L
    Oncology; 1995; 52(1):41-4. PubMed ID: 7800341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group.
    Vanhoefer U; Rougier P; Wilke H; Ducreux MP; Lacave AJ; Van Cutsem E; Planker M; Santos JG; Piedbois P; Paillot B; Bodenstein H; Schmoll HJ; Bleiberg H; Nordlinger B; Couvreur ML; Baron B; Wils JA
    J Clin Oncol; 2000 Jul; 18(14):2648-57. PubMed ID: 10894863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy in gastric cancer: an economic evaluation of the FAM (5-fluorouracil, adriamycin, mitomycin C) versus ELF (etoposide, leucovorin, 5-fluorouracil) regimens.
    Norum J; Angelsen V
    J Chemother; 1995 Oct; 7(5):455-9. PubMed ID: 8596132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preliminary clinical comparison of HLF and ELF regimen in the treatment of advanced gastric carcinoma in middle-aged and elderly patients].
    Xiong X; Zhu Z; Wen Z
    Zhonghua Zhong Liu Za Zhi; 2000 Sep; 22(5):411-3. PubMed ID: 11778280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II trial of etoposide, leucovorin and 5-fluorouracil (ELF) in patients with advanced gastric cancer.
    Au E; Koo WH; Tan EH; Ang PT
    J Chemother; 1996 Aug; 8(4):300-3. PubMed ID: 8873837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy comprising 5-fluorouracil, leucovorin, etoposide, and cis-diamminedichloroplatinum for the treatment of advanced gastric cancer.
    Mochizuki F; Fujii M; Kasakura Y; Yamagata M; Kochi M; Wakabayashi K; Kanamori N; Takayama T
    J Cancer Res Clin Oncol; 2002 Sep; 128(9):493-6. PubMed ID: 12242513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of patients with advanced gastric carcinoma with a 5-fluorouracil-based or a cisplatin-based regimen: two parallel randomized phase II studies.
    Barone C; Corsi DC; Pozzo C; Cassano A; Fontana T; Noviello MR; Landriscina M; Colloca G; Astone A
    Cancer; 1998 Apr; 82(8):1460-7. PubMed ID: 9554521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of advanced gastric cancer with etoposide, folinic acid, and fluorouracil in the clinical setting: efficacy of therapy and value of serum tumor markers.
    Schulze-Bergkamen H; Zuna I; Teufel A; Stremmel W; Rudi J
    Med Oncol; 2002; 19(1):43-53. PubMed ID: 12025890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weekly etoposide, epirubicin, cisplatin, 5-fluorouracil and leucovorin: an effective chemotherapy in advanced gastric cancer.
    Chi KH; Chao Y; Chan WK; Lo SS; Chen SY; Yen SH; Chen KY; Wu CW; Lee SD; Lui WY
    Br J Cancer; 1998 Jun; 77(11):1984-8. PubMed ID: 9667679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.